308 related articles for article (PubMed ID: 26192995)
1. Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain.
Rossotti MA; González-Techera A; Guarnaschelli J; Yim L; Camacho X; Fernández M; Cabral P; Leizagoyen C; Chabalgoity JA; González-Sapienza G
MAbs; 2015; 7(5):820-8. PubMed ID: 26192995
[TBL] [Abstract][Full Text] [Related]
2. Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells.
Rossotti M; Tabares S; Alfaya L; Leizagoyen C; Moron G; González-Sapienza G
Biochim Biophys Acta; 2015 Jul; 1850(7):1397-404. PubMed ID: 25819371
[TBL] [Abstract][Full Text] [Related]
3. High-Resolution Epitope Positioning of a Large Collection of Neutralizing and Nonneutralizing Single-Domain Antibodies on the Enzymatic and Binding Subunits of Ricin Toxin.
Vance DJ; Tremblay JM; Rong Y; Angalakurthi SK; Volkin DB; Middaugh CR; Weis DD; Shoemaker CB; Mantis NJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021300
[TBL] [Abstract][Full Text] [Related]
4. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
[TBL] [Abstract][Full Text] [Related]
5. Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin.
Cheng K; Lu J; Guo J; Wang R; Chen L; Wang X; Jiang Y; Li Y; Xu C; Kang Q; Qiaerxie G; Du P; Gao C; Yu Y; Yang Z; Wang W
Hum Vaccin Immunother; 2024 Dec; 20(1):2366641. PubMed ID: 38934499
[TBL] [Abstract][Full Text] [Related]
6. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
7. Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody.
Darvish M; Behdani M; Shokrgozar MA; Pooshang-Bagheri K; Shahbazzadeh D
Mol Immunol; 2015 Dec; 68(2 Pt B):412-20. PubMed ID: 26468036
[TBL] [Abstract][Full Text] [Related]
8. A novel nanobody against urease activity of Helicobacter pylori.
Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains.
Hussack G; Ryan S; van Faassen H; Rossotti M; MacKenzie CR; Tanha J
PLoS One; 2018; 13(12):e0208978. PubMed ID: 30540857
[TBL] [Abstract][Full Text] [Related]
10. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
Matsuda M; Makinaga G; Hirai T
Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
[TBL] [Abstract][Full Text] [Related]
11. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
12. Structural Characterization of Humanized Nanobodies with Neutralizing Activity against the Bordetella pertussis CyaA-Hemolysin: Implications for a Potential Epitope of Toxin-Protective Antigen.
Malik AA; Imtong C; Sookrung N; Katzenmeier G; Chaicumpa W; Angsuthanasombat C
Toxins (Basel); 2016 Apr; 8(4):99. PubMed ID: 27043627
[TBL] [Abstract][Full Text] [Related]
13. An innovative method for characterizing neutralizing antibodies against antibody-derived therapeutics.
Coddens A; Snoeck V; Bontinck L; Buyse MA; Pine SO
J Immunol Methods; 2020 Dec; 487():112896. PubMed ID: 33065122
[TBL] [Abstract][Full Text] [Related]
14. Differential neutralizing activities of a single domain camelid antibody (VHH) specific for ricin toxin's binding subunit (RTB).
Herrera C; Vance DJ; Eisele LE; Shoemaker CB; Mantis NJ
PLoS One; 2014; 9(6):e99788. PubMed ID: 24918772
[TBL] [Abstract][Full Text] [Related]
15. Random phage-epitope library based identification of a peptide antagonist of Mac-1 β2 integrin ligand binding.
Houimel M; Mazzucchelli L
Matrix Biol; 2012 Jan; 31(1):66-77. PubMed ID: 22100634
[TBL] [Abstract][Full Text] [Related]
16. Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity.
Ji X; Lu W; Zhou H; Han D; Yang L; Wu H; Li J; Liu H; Zhang J; Cao P; Zhang S
Appl Microbiol Biotechnol; 2013 Oct; 97(19):8547-58. PubMed ID: 23324801
[TBL] [Abstract][Full Text] [Related]
17. Human antibodies neutralizing diphtheria toxin in vitro and in vivo.
Wenzel EV; Bosnak M; Tierney R; Schubert M; Brown J; Dübel S; Efstratiou A; Sesardic D; Stickings P; Hust M
Sci Rep; 2020 Jan; 10(1):571. PubMed ID: 31953428
[TBL] [Abstract][Full Text] [Related]
18. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
[TBL] [Abstract][Full Text] [Related]
19. Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity.
Rudolph MJ; Vance DJ; Kelow S; Angalakurthi SK; Nguyen S; Davis SA; Rong Y; Middaugh CR; Weis DD; Dunbrack R; Karanicolas J; Mantis NJ
Protein Eng Des Sel; 2018 Jul; 31(7-8):277-287. PubMed ID: 30265352
[TBL] [Abstract][Full Text] [Related]
20. In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody.
Richard G; Meyers AJ; McLean MD; Arbabi-Ghahroudi M; MacKenzie R; Hall JC
PLoS One; 2013; 8(7):e69495. PubMed ID: 23894495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
